USPTO serial 86303672
LIFNEBE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 15, 2015
- Examiner
- MORENO, PAUL A
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with LIFNEBE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Brentford, Middlesex, GB
Brentford, Middlesex, GB
Brentford, Middlesex, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christopher M. Hanes
CHRISTOPHER M. HANES GLAXOSMITHKLINEFive Moore DriveLegal Global Trademarks, Mailstop: 5.5AResearch Triangle Park, NC 27709-0183Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 25, 2022 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Sep 15, 2020 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Sep 15, 2015 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 30, 2015 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 30, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 23, 2015 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 10, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 28, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 20, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 14, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 14, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 8, 2015 | ALIE | ASSIGNED TO LIE | — |
| May 5, 2015 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Mar 26, 2015 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Mar 26, 2015 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Mar 26, 2015 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Sep 19, 2014 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Sep 19, 2014 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Sep 19, 2014 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Sep 18, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 19, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 12, 2014 | NWAP | NEW APPLICATION ENTERED | — |